These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 6091392

  • 1. Misonidazole neuropathy.
    Paulson OB, Melgaard B, Hansen HS, Kamieniecka Z, Køhler O, Hansen JM, Pedersen AG, Tang X, Trojaborg W.
    Acta Neurol Scand Suppl; 1984; 100():133-6. PubMed ID: 6091392
    [Abstract] [Full Text] [Related]

  • 2. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
    Melgaard B, Hansen HS, Kamieniecka Z, Paulson OB, Pedersen AG, Tang X, Trojaborg W.
    Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
    [Abstract] [Full Text] [Related]

  • 3. Misonidazole neuropathy. A prospective study.
    Melgaard B, Køhler O, Sand Hansen H, Overgaard J, Munck-Hansen J, Paulson OB.
    J Neurooncol; 1988 Nov; 6(3):227-30. PubMed ID: 3066854
    [Abstract] [Full Text] [Related]

  • 4. Electroneurographic investigations of misonidazole polyneuropathy.
    Mamoli B, Wessely P, Kogelnik HD, Müller M, Rathkolb O.
    Eur Neurol; 1979 Nov; 18(6):405-14. PubMed ID: 232682
    [Abstract] [Full Text] [Related]

  • 5. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
    Walker MD, Strike TA.
    Cancer Clin Trials; 1980 Nov; 3(2):105-9. PubMed ID: 6253094
    [Abstract] [Full Text] [Related]

  • 6. Peripheral neuropathy related to misonidazole: incidence and pathology.
    Urtasun RC, Chapman JD, Feldstein ML, Band RP, Rabin HR, Wilson AF, Marynowski B, Starreveld E, Shnitka T.
    Br J Cancer Suppl; 1978 Jun; 3():271-5. PubMed ID: 209809
    [Abstract] [Full Text] [Related]

  • 7. Plasma concentration of misonidazole and peripheral neuropathy.
    Marten TR.
    Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical experience with misonidazole: high dose fractions versus daily low doses.
    Kogelnik HD.
    Cancer Clin Trials; 1980 Apr; 3(2):179-86. PubMed ID: 6253098
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.
    Jones DH, Bleehen NM, Workman P, Smith NC.
    Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878
    [Abstract] [Full Text] [Related]

  • 16. Neurotoxicity of Adriamycin and misonidazole in the mouse.
    Boegman RJ, Scarth B, Dragovic L, Robertson DM.
    Exp Neurol; 1985 Jan; 87(1):1-8. PubMed ID: 2981696
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
    Wasserman TH, Phillips TL, Van Raalte G, Urtasun R, Partington J, Koziol D, Schwade JG, Gangji D, Strong JM.
    Br J Radiol; 1980 Feb; 53(626):172-3. PubMed ID: 6245744
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.